Anna Mariuk-Jarema

Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study

Piotr Rutkowski, Alice Indini, Matilde De Luca et al. · Journal for ImmunoTherapy of Cancer · 2020 · 59 citations · Full text

Medicine, Biostatistics, Oncology +17

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice

Anna M. Czarnecka, Paweł Teterycz, Anna Mariuk-Jarema et al. · Targeted Oncology · 2019 · 24 citations

Medicine, Clinical Sciences, Oncology +16

Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence

Anna M. Czarnecka, Paweł Sobczuk, Paweł Rogala et al. · Cancer Immunology Immunotherapy · 2022 · 15 citations · Full text

Medicine, Immunology, Oncology +16

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors

Paweł Teterycz, Paulina Jagodzińska-Mucha, Bożena Cybulska-Stopa et al. · Melanoma Research · 2018 · 12 citations

Medicine, Hematology, Oncology +17

A durable complete response to immunotherapy in a patient with metastatic alveolar soft part sarcoma

Anna Mariuk-Jarema, Hanna Koseła-Paterczyk, Paweł Rogala et al. · Tumori Journal · 2020 · 11 citations

Medicine, Immunology, Oncology +14